D3A.012 Benign carcinoid tumor of the ileum

Name of the Condition

• Benign carcinoid tumor of the ileum

Summary

Benign carcinoid tumors of the ileum are non-cancerous growths that arise from neuroendocrine cells in the ileum, the final section of the small intestine. These tumors are typically slow-growing and may or may not produce hormones, depending on their specific characteristics. They are part of a broader category of neuroendocrine tumors and are often discovered incidentally during imaging or endoscopic procedures.

Causes

The exact causes of benign carcinoid tumors of the ileum are not fully understood. They may develop due to genetic mutations or imbalances in cell growth regulation. Some cases occur sporadically, while others are linked to inherited genetic syndromes affecting neuroendocrine cell function.

Risk Factors

Risk factors include a family history of neuroendocrine tumors or genetic syndromes such as Multiple Endocrine Neoplasia (MEN) syndrome. Age and gender may also play a role, with certain tumors more common in middle-aged adults. Underlying conditions like chronic inflammatory bowel disease or celiac disease may increase risk in some cases.

Symptoms

Symptoms vary based on the tumor's location and hormone production. They may include abdominal pain, changes in bowel habits, unexplained weight loss, or flushing. Some tumors are asymptomatic and discovered incidentally during imaging for unrelated reasons.

Diagnosis

Diagnosis involves a combination of imaging studies (e.g., CT scans, MRI, or endoscopic procedures) and biopsy to confirm the tumor type. Blood and urine tests may be used to detect hormone levels if the tumor is suspected of producing excess hormones. Histopathological examination is essential to rule out malignancy.

Treatment Options

Treatment depends on the tumor's size, location, and symptoms. Small, asymptomatic tumors may be monitored with regular imaging. Symptomatic or larger tumors may require surgical removal. Endoscopic resection is an option for accessible tumors. Hormone-secreting tumors may be managed with medications to control symptoms.

Prognosis and Follow-Up

Prognosis is generally favorable for benign carcinoid tumors of the ileum, as they are non-cancerous and slow-growing. Follow-up care typically includes regular imaging and clinical evaluations to monitor for recurrence or changes. Long-term outcomes are good with appropriate management.

Complications

Complications are rare but may include bowel obstruction, bleeding, or hormone-related symptoms if the tumor produces excess hormones. In rare cases, the tumor may grow large enough to cause mechanical issues in the intestine.

Lifestyle & Prevention

There are no specific lifestyle changes to prevent benign carcinoid tumors of the ileum. Maintaining overall digestive health and managing underlying conditions (e.g., inflammatory bowel disease) may support general well-being. Regular medical check-ups are recommended for those with risk factors.

When to Seek Professional Help

Seek medical attention if you experience persistent abdominal pain, unexplained weight loss, changes in bowel habits, or symptoms like flushing. Early evaluation is important if a tumor is suspected or discovered incidentally during imaging.

Tips for Medical Coders

Use code D3A.012 for benign carcinoid tumors of the ileum. Ensure documentation specifies the tumor's location (ileum) and confirms benign behavior. Differentiate from malignant carcinoid tumors or other neuroendocrine neoplasms. Verify that the diagnosis aligns with clinical findings and histopathological reports.